Side-by-side comparison of AI visibility scores, market position, and capabilities
Cofertility matches women who want to freeze eggs for their future with intended parents who need donor eggs, reducing the cost of freezing by sharing eggs with recipients.
Cofertility is a fertility technology company founded in 2021 that has created a unique egg sharing model connecting women who want to freeze their eggs with intended parents who need donor eggs. Through the platform's Split program, egg donors freeze half of their eggs for their own future use while the other half goes to recipients, with the recipient paying for the donor's entire egg freezing cycle. This arrangement makes egg freezing free for donors who would otherwise pay $10,000 or more out of pocket, while providing recipients with a younger, more diverse egg donor pool. Cofertility raised $30M and has built the largest technology-first egg donation platform, emphasizing donor safety, informed consent, and transparent compensation practices that differ from traditional egg donation agencies. The company screens donors and handles all clinical coordination with partner fertility clinics. Cofertility addresses both the financial barrier to egg freezing that prevents many women from accessing this preventive care and the limited supply of diverse egg donors that many intended parents face. The platform represents a novel market structure that creates value for donors, recipients, and the overall fertility ecosystem simultaneously.
London and New York AI platform automating insurance prior authorization; reads patient clinical records to extract evidence justifying medical necessity and cut treatment delays.
Anterior is a London and New York-based healthtech company that applies AI to automate the prior authorization process, one of the most burdensome administrative tasks in U.S. healthcare. Prior authorization requires physicians to submit clinical evidence to insurance companies justifying the medical necessity of treatments, procedures, or medications — a process that consumes significant physician and staff time and causes treatment delays that harm patient outcomes. Anterior's AI reads patient clinical records, identifies the relevant clinical criteria required by the insurer, extracts supporting evidence from the patient's history, and generates complete prior auth submissions automatically. The platform also predicts approval likelihood and flags cases likely to require clinical review, helping health system staff prioritize their work. Founded in 2022, Anterior raised funding from investors including Sequoia Capital and has rapidly signed health system customers facing acute prior authorization burdens. The company's approach addresses a systemically inefficient process that costs the U.S. healthcare system an estimated $35B annually in administrative waste.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.